Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 NATCO PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    NATCO PHARMA
Mar-23
ADCOCK INGRAM
Jun-14
NATCO PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs847314-   
Low Rs502226-   
Sales per share (Unadj.) Rs148.493.4-  
Earnings per share (Unadj.) Rs39.2-23.5-  
Cash flow per share (Unadj.) Rs48.2-19.5-  
Dividends per share (Unadj.) Rs5.500-  
Avg Dividend yield %0.80-  
Book value per share (Unadj.) Rs267.173.3-  
Shares outstanding (eoy) m182.47168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.52.9 157.1%   
Avg P/E ratio x17.2-11.5 -149.8%  
P/CF ratio (eoy) x14.0-13.9 -101.0%  
Price / Book Value ratio x2.53.7 68.5%  
Dividend payout %14.00-   
Avg Mkt Cap Rs m123,04945,603 269.8%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m4,8672,862 170.0%   
Avg. sales/employee Rs Th03,671.4-  
Avg. wages/employee Rs Th0666.7-  
Avg. net profit/employee Rs Th0-925.1-  
INCOME DATA
Net Sales Rs m27,07115,761 171.8%  
Other income Rs m1,285110 1,164.2%   
Total revenues Rs m28,35615,872 178.7%   
Gross profit Rs m9,117-2,731 -333.8%  
Depreciation Rs m1,638680 240.8%   
Interest Rs m145427 34.0%   
Profit before tax Rs m8,619-3,728 -231.2%   
Minority Interest Rs m0-10 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,466233 629.3%   
Profit after tax Rs m7,153-3,971 -180.1%  
Gross profit margin %33.7-17.3 -194.3%  
Effective tax rate %17.0-6.2 -272.2%   
Net profit margin %26.4-25.2 -104.9%  
BALANCE SHEET DATA
Current assets Rs m30,00311,544 259.9%   
Current liabilities Rs m6,8316,495 105.2%   
Net working cap to sales %85.632.0 267.2%  
Current ratio x4.41.8 247.1%  
Inventory Days Days63111 57.2%  
Debtors Days Days115124 93.1%  
Net fixed assets Rs m26,5716,729 394.9%   
Share capital Rs m36573 498.8%   
"Free" reserves Rs m48,3730-   
Net worth Rs m48,73812,371 394.0%   
Long term debt Rs m04,347 0.0%   
Total assets Rs m56,57423,369 242.1%  
Interest coverage x60.4-7.7 -781.7%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.50.7 70.9%   
Return on assets %12.9-15.2 -85.1%  
Return on equity %14.7-32.1 -45.7%  
Return on capital %18.0-19.8 -90.8%  
Exports to sales %00-   
Imports to sales %10.20-   
Net fx Rs m14,4840-   
CASH FLOW
From Operations Rs m8,4911,345 631.1%  
From Investments Rs m-4,771-413 1,155.0%  
From Financial Activity Rs m-3,6303,945 -92.0%  
Net Cashflow Rs m2084,878 4.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.33 Rs / ZAR

Compare NATCO PHARMA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare NATCO PHARMA With: CHEMO PHARMA  AAYUSH FOOD & HERBS   SUPRIYA LIFESCIENCE   AVON ORGANIC  FABINO LIFE   



Today's Market

Sensex Today Trades Flat | Nifty Below 22,350 | Kotak Mahindra Bank Tanks 9% Sensex Today Trades Flat | Nifty Below 22,350 | Kotak Mahindra Bank Tanks 9%(10:30 am)

Asian stocks fell on Thursday as disappointing earnings forecasts from Facebook parent Meta Platforms hammered tech shares, while the yen's slump past 155 per dollar.